GNLX
GENELUX Corp
NASDAQ · Healthcare · Biotechnology · US
$2.53
+0.00%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.20
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.21
- EPS estimate
- -$0.20
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 9
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -4.6%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.20 | -$0.21 | Miss -6.78% | — |
| May 7, 2026 | -$0.18 | -$0.20 | Miss -11.11% | — |
| Mar 19, 2026 | -$0.22 | -$0.24 | Miss -9.09% | $8.0K |
| Nov 5, 2025 | -$0.23 | -$0.21 | Beat 8.70% | — |
| Aug 7, 2025 | -$0.22 | -$0.20 | Beat 9.09% | — |
| Mar 28, 2025 | -$0.17 | -$0.26 | Miss -52.94% | $452.0K |
| Nov 14, 2024 | -$0.19 | -$0.19 | In line | — |
| Aug 14, 2024 | -$0.19 | -$0.22 | Miss -15.79% | — |
| May 9, 2024 | -$0.23 | -$0.29 | Miss -26.09% | $8.0K |
| Nov 14, 2023 | -$0.12 | -$0.20 | Miss -66.67% | — |
| Aug 14, 2023 | -$0.15 | -$0.23 | Miss -53.33% | — |
| May 15, 2023 | -$0.16 | -$0.53 | Miss -230.89% | $170.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026